Instructions Resistol tablets No. 20
Composition
1 film-coated tablet contains:
active ingredient: dry extract of pelargonium roots (Pelargonium sidoides DC and/or Pelargonium reniforme Curt., radix (4–7:1)), (extractant — ethanol 14% v/v) — 20 mg;
excipients:
for dry extract: powdered cellulose, colloidal anhydrous silicon dioxide;
for the tablet core: lactose monohydrate; silicified microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silicon dioxide; calcium stearate;
The coating mixture contains: partially hydrolyzed polyvinyl alcohol, polyethylene glycol (macrogol) 3350, talc, titanium dioxide (E 171), sunset yellow FCF dye (E 110), special red AG dye (E 129), indigo carmine dye (E 132).
Dosage form
Film-coated tablets.
Main physicochemical properties: Film-coated tablets, brown with a reddish tint, round in shape with a biconvex surface.
Pharmacotherapeutic group
Remedies used for coughs and colds.
ATX code R05.
Pharmacological properties
RESISTOL®-TAB is a traditional herbal medicine for use according to indications confirmed by long-term use.
Pharmacodynamics
The drug contains an extract from the roots of Pelargonium sidoides DC and/or Pelargonium reniforme Curt., which stimulates nonspecific defense mechanisms of the body, has moderate antibacterial and antiviral properties (direct and indirect mechanisms), cytoprotective properties. Also, the extract from the roots of pelargonium stimulates the mucociliary system and alleviates the course of the disease.
Pharmacokinetics
Data on the pharmacokinetics of the medicinal product are not required.
Indication
Symptomatic treatment of colds.
Contraindication
Hypersensitivity to the active substance of the drug or to any of the excipients. Increased tendency to bleeding, simultaneous administration of drugs that slow down the blood clotting process; severe liver and kidney diseases (due to lack of sufficient experience of using this drug in such cases).
Interaction with other medicinal products and other types of interactions
Unknown. Since the drug may alter blood clotting parameters, the possibility of influencing the action of indirect anticoagulants such as warfarin cannot be ruled out.
The patient should inform the doctor about all the medicines he is taking or has taken recently, as well as about the medicines he plans to use.
Application features
Do not exceed the recommended daily dose.
If the symptoms of the disease do not disappear within one week, the elevated body temperature persists for more than 3 days or the general condition worsens, or if shortness of breath and bloody sputum are observed, you should immediately consult a doctor.
Cases of hepatic dysfunction and hepatitis have been reported in association with the drug. If signs of hepatotoxicity occur, the drug should be discontinued immediately and a doctor should be consulted.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
The medicine contains the dye sunset yellow (E 110), which may cause allergic reactions.
Use during pregnancy or breastfeeding
There are no data on the effect on fertility.
There is no data on the safety of use during pregnancy and lactation.
Due to the lack of data, it is not recommended to use the drug during pregnancy or breastfeeding.
The ability to influence the reaction speed when driving or working with other mechanisms
There are no studies on the effect of the drug on the ability to drive or operate other mechanisms.
Method of administration and doses
Adults and children over 12 years of age: 1 tablet 3 times a day (morning, afternoon and evening); children from 6 to 12 years of age: 1 tablet 2 times a day (morning and evening).
It is recommended to take RESISTOL®-TAB without chewing, with a small amount of liquid.
The duration of use depends on the severity and course of the disease and is determined by the doctor individually.
If, despite following the prescribed dosage, symptoms persist for more than 1 week, the patient should consult a doctor.
Children
Prescribed for children aged 6 years and older. Efficacy and safety of use in children under 6 years of age have not been established.
Overdose
To date, there have been no reports of overdose.
Side effects
On the part of the digestive tract: digestive tract disorders (including stomach pain, heartburn, nausea, diarrhea), slight bleeding from the gums.
Respiratory system: mild nosebleeds.
Hepatobiliary system: increased liver function tests. A causal relationship between the increase in these tests and the use of the drug has not been demonstrated.
Expiration date
2 years.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging
10 tablets in a blister, 2 blisters in a pack.
Vacation category
Without a prescription.
Producer
PJSC "Kyivmedpreparat".
Address
Ukraine, 01032, Kyiv, Saksaganskoho St., 139.
